Psychobiological modulation in anxious and depressed patients after a mindfulness meditation programme: A pilot study

Stress and Health

Volumn 27, Issue 3, 2011, Pages 216-222

  Manzaneque, Juan M ^a   Vera, Francisca M ^a   Ramos, Natalia S ^a   Godoy, Yelba A ^a   Rodriguez, Francisco M ^a   Blanca, Maria J ^a   Fernandez, Ana ^b   Enguix, Alfredo ^b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

endocrine parameters; mindfulness meditation; psychological well being

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; LIOTHYRONINE; PARATHYROID HORMONE; PRASTERONE SULFATE; THYROTROPIN; THYROXINE;

5 ITEM MENTAL HEALTH; ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LIOTHYRONINE BLOOD LEVEL; MALE; MEDITATION; MENTAL PATIENT; MINDFULNESS MEDITATION PROGRAM; PARATHYROID HORMONE BLOOD LEVEL; PILOT STUDY; PSYCHOBIOLOGY; PSYCHOLOGICAL WELL BEING; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION;

EID: 80051767236     PISSN: 15323005     EISSN: 15322998     Source Type: Journal    
DOI: 10.1002/smi.1334     Document Type: Article

References (42)

1. Alonso, J., Prieto, L., &, Anto, J.M., (1995). The Spanish version of SF-36 Health Survey: An instrument for measuring clinical outcome [La versión española del Cuestionario de Salud SF-36: un instrumento para la medida de los resultados clínicos]. Medicina Clínica, 104, 771-776.
2. Astin, J.A., Berman, B.M., Bausell, B., Lee, W.L., Hochberg, M., &, Forys, K.L., (2003). The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: A randomized controlled trial. Journal of Rheumatology, 30 (10), 2257-2262. (Pubitemid 37221861)
3. Buford, T.W., &, Willoughby, D.S., (2008). Impact of DHEA(S) and cortisol on immune function in aging: A brief review. Applied Physiology, Nutrition, and Metabolism, 33, 429-433.
4. Carlson, L.E., Speca, M., Faris, P., &, Patel, KD., (2007). One year pre-post interventions follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain, Behavior, and Immunity, 21, 1038-1049. (Pubitemid 47496126)
5. Carlson, L.E., Speca, M., Patel K.D., &, Goodey E., (2004). Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate outpatients. Psychoneuroendocrinology, 29, 448-474. (Pubitemid 38121602)
6. Chiba, Y., Satoh, K., Ueda, S., Kanazawa, N., Tamura, Y., &, Horiuchi, T., (2007). Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism. Endocrine Journal, 54, 379-383. (Pubitemid 47105424)
7. Gartside, S., Griffith, N., Kaura, V., &, Ingram, C., (2009). The neurosteroid dehydroepiandrosterone (DHEA) and its metabolites alter 5-HT neuronal activity via modulation of GABAA receptors. Journal of Psychopharmacology, DOI:10.1177/0269881109105836
8. Genud, R., Merenlender, A., Gispan-Herman, I., Maayan, R., Weizman, A., &, Yadid, G., (2008). DHEA lessens depressive-like behavior via gaba-ergic modulation of the mesolimbic system. Neuropsychopharmacology, 34 (3), 577-584.
9. Glaser, J.L., Brind, J.L., Vogelman, J.H., Eisner, M.J., Dillbeck, M.C., Wallace, R.K., Chopra, D., &, Orentreich, N., (1992). Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs. Journal of Behavioral Medicine, 15, 327-341.
10. Gross, C.R., Kreitzer, M.J., Russas, V., Treesak, C., Fraziers, A., &, Hertz, M.I., (2004). Mindfulness meditation to reduce symptoms after organ transplant: A pilot study. Advances in Mind Body Medicine, 20, 20-29. (Pubitemid 39136291)
11. Hirao, K., Kikawada, M., Otoguro, M., Sato, T., Sakurai, H., Hanyu, H., &, Iwamoto, T., (2007). Elderly case of isolated ACTH deficiency presenting with depression and digestive symptoms. Nippon Ronen Igakkai Zasshi, 44, 117-121.
12. Hoogendijk, W.J., Lips, P., Dik, M.G., Deeg, D.J., Beekman, A.T., &, Penninx, B.W., (2008). Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Archives of General Psychiatry, 65, 508-512. (Pubitemid 351645046)
13. Infante, J.R., Peran, F., Martinez, M., Roldan, A., Poyatos, R., Ruiz, C., Samaniego, F., &, Garrido, F., (1998). ACTH and beta-endorphin in transcendental meditation. Physiology & Behavior, 64, 311-315.
14. Jeckel, C.M., Lopes, R.P., Berleze, M.C., Luz, C., Feix, L., Argimon, I.I., Stein, L.M, &, Bauer, M.E., (2010). Neuroendocrine and immunological correlates of chronic stress in 'strictly healthy' populations. Neuroimmunomodulation, 17 (1), 9-18.
15. Jevning, R., Wilson, A.F., Pirkle, H., Guich, S., &, Walsh, R.N., (1985). Modulation of red cell metabolism by states of decreased activation: Comparison between states. Physiology & Behavior, 35, 679-682. (Pubitemid 16253591)
16. Kabat-Zinn, J., Lipworth, L., &, Burney, R., (1985). The clinical use of mindfulness meditation for the self-regulation of chronic pain. Journal of Behavioral Medicine, 8, 163-190. (Pubitemid 15023685)
17. Kabat-Zinn, J., Wheeler, E., Light, T., Skillings, A., Scharf, M.J., Cropley, G., Hosmer, D., &, Bernhard, J.D., (1998). Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosomatic Medicine, 60, 625-632. (Pubitemid 28453029)
18. Kathol, R.G., Jaeckle, R.S., Lopez, J.F., &, Meller, W.H., (1989). Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression. British Journal of Psychiatry, 155, 468-478. (Pubitemid 19241583)
19. Kawai, K., Tamai, H., Nishikata, H., Kobayashi, N., &, Matsubayashi, S., (1994). Severe depression associated with ACTH, PRL, and GH deficiency: A case report. Endocrine Journal, 41, 275-279. (Pubitemid 24237306)
20. Kikuchi, M., Komuro, R., Oka, H., Kidani, T., Hanaoka, A., &, Koshino, Y., (2005). Relationship between anxiety and thyroid function in patients with panic disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29 (1), 77-81. (Pubitemid 40018208)
21. Lush, E., Salmon, P., Floyd, A., Studts, J.L., Weissbecker, I., &, Sephton, S.E., (2009). Mindfulness meditation for symptom reduction in fibromyalgia: Psychophysiological correlates. Journal of Clinical Psychology in Medical Settings, 16 (2), 200-207.
22. MacLean, C.R., Walton, K.G., Wenneberg, S.R., Levitsky, D.K., Mandarino, J.P., Waziri, R., Hillis, S.L., &, Schneider, R.H., (1997). Effects of Transcendental Meditation program on adaptive mechanisms: Changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology, 22, 277-295. (Pubitemid 27305570)
23. MacLean, C.R., Walton, K.G., Wenneberg, S.R., Levitsky, D.K., Mandarino, J.P., Waziri, R., &, Schneider, R.H., (1994). Altered responses of cortisol, GH, TSH, and testosterone to acute stress after four months' practice of transcendental meditation (TM). Annals of the New York Academy of Sciences, 30, 381-384. (Pubitemid 26005912)
24. McComb, J.J., Tacon, A., Randolph, P., &, Caldera, Y., (2004). A pilot study to examine the effects of a mindfulness-based stress-reduction and relaxation program on levels of stress hormones, physical functioning and submaximal exercise responses. Journal of Alternative and Complementary Medicine, 10, 819-827. (Pubitemid 39507037)
25. Miller, J.J., Fletcher, K., &, Kabat-Zinn, J., (1995). Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. General Hospital Psychiatry, 17, 192-200.
26. Morone, N.E., Lynch, C.S., Greco, C.M., Tindle, H.A., &, Weiner, D.K., (2008). 'I felt like a new person.' The effects of mindfulness meditation on older adults with chronic pain: Qualitative narrative analysis of diary entries. Journal of Pain, 9 (9), 841-848.
27. Ong, J.C., Shapiro, S.L., &, Manber, R., (2008). Combining mindfulness meditation with cognitive-behavior therapy for insomnia: A treatment-development study. Behavior Therapy, 39, 171-182. (Pubitemid 351697901)
28. Sears, S., &, Kraus, S., (2009). I think therefore I am: Cognitive distortions and coping style as mediators for the effects of mindfulness meditation on anxiety, positive and negative affect, and hope. Journal of Clinical Psychology, 65 (6), 561-573.
29. Sephton, S.E., Salmon, P., Weissbecker, I., Ulmer, C., Floyd, A., Hoover, K., &, Studts, J.L., (2007). Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: Results of a randomized clinical trial. Arthritis and Rheumatism, 57, 77-85.
30. Shapiro, S.L., Carlson, L.E., Astin, J.A., &, Freedman, B., (2006). Mechanisms of mindfulness. Journal of Clinical Psychology, 62, 373-386.
31. Simpson, T.L., Kaysen, D., Bowen, S., MacPherson, L.M., Chawla, N., Blume, A., Marlatt, G.A., &, Larimer, M., (2007). PTSD symptoms, substance use, and vipassana meditation among incarcerated individuals. Journal of Traumatic Stress, 20, 239-249. (Pubitemid 47075437)
32. Speca, M., Carlson, L.E., Goodey, E., &, Angen, M., (2000). A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosomatic Medicine, 62, 613-622.
33. Stipcevic, T., Pivac, N., Kozaric-Kovacic, D., &, Mück-Seler, D., (2008). Thyroid activity in patients with major depression. Collegium Antropologicum, 32 (3), 973-976.
34. Strous, R.D., (2005). Dehydroepiandrosterone (DHEA) augmentation in the management of schizophrenia symptomatology. Essential Psychopharmacology, 6 (3), 141-147.
35. Tacon, A.M., McComb, J., Caldera, Y., &, Randolph, P., (2003). Mindfulness meditation, anxiety reduction, and heart disease: A pilot study. Family & Community Health, 26, 25-33.
36. Toneatto, T., &, Nguyen, L., (2007). Does mindfulness meditation improve anxiety and mood symptoms? A review of the controlled research. Canadian Journal of Psychiatry, 52, 260-266. (Pubitemid 46743474)
37. Von Weiss, D., (2002). Use of mindfulness meditation for fibromyalgia. American Family Physician, 65, 380-384.
38. Walton, K.G., Pugh, N.D., Gelderloos, P., &, Macrae, P., (1995). Stress reduction and preventing hypertension: Preliminary support for a psychoneuroendocrine mechanism. Journal of Alternative and Complementary Medicine, 1, 263-283.
39. Ware, J.E., &, Sherbourne, C.D., (1992). The MOS 36-item short-form health survey (SF-36). Medical Care, 30 (6), 473-483.
40. Werner, O.R., Wallace, R.K., Charles, B., Janssen, G., Stryker, T., &, Chalmers, R.A., (1986). Long-term endocrinologic changes in subjects practicing the Transcendental Meditation and TM-Sidhi program. Psychosomatic Medicine, 48, 59-66. (Pubitemid 16163286)
41. Zautra, A.J., Davis, M.C., Reich, J.W., Nicassario, P., Tennen, H., Finan, P., Kratz, A., Parrish, B., &, Irwin, M.R., (2008). Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. Journal of Consulting and Clinical Psychology, 76, 408-421. (Pubitemid 351822341)
42. Zylowska, L., Ackerman, D.L., Yang, M.H., Futrell, J.L., Horton, N.L., Hale, T.S., Pataki, C., &, Smalley, S.L., (2008). Mindfulness meditation training in adults and adolescents with ADHD: A feasibility study. Journal of Attention Disorders, 11, 737-746.